Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study.

Ravish H S,Akash khobragade,Durga Madhab Satapathy,Monica Gupta,Surendra Kumar,Vinay Bhomia,Ramasubramanian,Maharshi Desai,Ashok Dilipkumar Agrawal

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study.

2021

Ravish H S
Akash khobragade
Durga Madhab Satapathy
Monica Gupta
Surendra Kumar
Vinay Bhomia
Ramasubramanian
Maharshi Desai
Ashok Dilipkumar Agrawal

Rabies vaccines are lifesaving in human post animal exposure. However, the compliance to the complete course of vaccine is found to be only 60%. Hence, there is a need for safe and immunogenic, sho...

Keywords:

post exposure
ANIMAL EXPOSURE
Recombinant DNA
Rabies
immunization
Immunogenicity
clinical study
Pharmacology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations